MX9403275A - Metilendioxi[3,'4':6,7]indolizino-[1,2-b]quinolinonas substituidas. - Google Patents

Metilendioxi[3,'4':6,7]indolizino-[1,2-b]quinolinonas substituidas.

Info

Publication number
MX9403275A
MX9403275A MX9403275A MX9403275A MX9403275A MX 9403275 A MX9403275 A MX 9403275A MX 9403275 A MX9403275 A MX 9403275A MX 9403275 A MX9403275 A MX 9403275A MX 9403275 A MX9403275 A MX 9403275A
Authority
MX
Mexico
Prior art keywords
substituted
quinolinonas
methylendioxi
indolizino
compounds
Prior art date
Application number
MX9403275A
Other languages
English (en)
Inventor
William Dennis Kingsbury
Israil Pendrak
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of MX9403275A publication Critical patent/MX9403275A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se describen en la presente composiciones demetilendioxiindolizino[1,2-b]quinolinonas, substituidas, antivirales, quecomprenden dichos compuestos, y un método para tratar infecciones viralesusando dichos compuestos.
MX9403275A 1993-05-03 1994-05-03 Metilendioxi[3,'4':6,7]indolizino-[1,2-b]quinolinonas substituidas. MX9403275A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5713393A 1993-05-03 1993-05-03
US21365794A 1994-03-15 1994-03-15

Publications (1)

Publication Number Publication Date
MX9403275A true MX9403275A (es) 1995-01-31

Family

ID=26736111

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9403275A MX9403275A (es) 1993-05-03 1994-05-03 Metilendioxi[3,'4':6,7]indolizino-[1,2-b]quinolinonas substituidas.

Country Status (7)

Country Link
EP (1) EP0699201A1 (es)
JP (1) JPH08509742A (es)
AU (1) AU684777B2 (es)
CA (1) CA2161980A1 (es)
MX (1) MX9403275A (es)
NZ (1) NZ266094A (es)
WO (1) WO1994025465A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5883255A (en) * 1990-10-31 1999-03-16 Smithkline Beecham Corporation Substituted indolizino 1,2-b!quinolinones

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5829793B2 (ja) * 1975-02-07 1983-06-24 日本ケミフア （株） ７−アルコキシカルボニル−８−メチルインドリジノ〔１，２−ｂ〕キノリン−９（１１Ｈ）−オンの製法
US4981968A (en) * 1987-03-31 1991-01-01 Research Triangle Institute Synthesis of camptothecin and analogs thereof
CA1332413C (en) * 1987-06-25 1994-10-11 Kabushiki Kaisha Yakult Honsha Camptothecin derivatives and process for preparing same
US5225404A (en) * 1989-11-06 1993-07-06 New York University Methods of treating colon tumors with tumor-inhibiting camptothecin compounds
AU8940491A (en) * 1990-10-31 1992-05-26 Smithkline Beecham Corporation Substituted indolizino(1,2-b)quinolinones
EP0540099B1 (en) * 1991-10-29 1996-04-17 Glaxo Wellcome Inc. Water soluble camptothecin derivatives
JPH05191297A (ja) * 1992-01-10 1993-07-30 Fujitsu Ltd シリアル／パラレル変換回路

Also Published As

Publication number Publication date
EP0699201A4 (en) 1996-01-22
AU6670494A (en) 1994-11-21
JPH08509742A (ja) 1996-10-15
EP0699201A1 (en) 1996-03-06
AU684777B2 (en) 1998-01-08
NZ266094A (en) 1997-10-24
WO1994025465A1 (en) 1994-11-10
CA2161980A1 (en) 1994-11-10

Similar Documents

Publication Publication Date Title
DK0509019T3 (da) Behandling af humane retrovirale infektioner med 2',3'-dideoxyinosin
EP0528858A4 (en) Inhibitors of dipeptidyl-aminopeptidase type iv
ES2191292T3 (es) Compuestos antivirales poliaromaticos.
CA2263561A1 (en) Thienopyrimidines
NO954186D0 (no) Plaster med aktive bestanddeler
ES2176402T3 (es) Compuestos sulfatos de 2,2-difluoro-3-carbomoil-ribosa y procedimientopara la preparacion de beta-nucleosidos.
PT723538E (pt) Compostos triciclicos de carbamato uteis para a ainibicao da funcao da proteina g e para o tratamento de doencas proliferativas
DK42093D0 (da) Administrationsmetode
BR9815166A (pt) "método de inibição da replicação de vìrus, composto, método de inibição da replicação de citomegalovìrus, composto antiviral, utilização de um composto, composição farmacêutica, composição farmacêutica inibidora da replicação de vìrus e de citomegalovìrus e composição farmacêutica antiviral"
FR2709754B1 (fr) Composés 2' ou 3'-déoxy- et 2', 3'-didéoxy-beta-L-pentofuranonucléosides, procédé de préparation et application thérapeutique, notamment anti-virale.
YU74292A (sh) Jedinjenja za inhibiciju hiv i srodnih virusa
DE69624340T2 (de) Pharmazeutische zusammensetzung zur behandlung von herpes
AU7855191A (en) 2',3'-dideoxy-4'-thioribonucleosides as antiviral agents
ES2191075T3 (es) 8-arilalquil- y 8-arilheteroalquil-5,11-dihidro-6h-dipirido-(3,2-b:2',3'-e)(1,4)diazepinas y su uso en la prevencion o tratamiento de infecciones por hiv.
FI933957A0 (fi) Polyolefinpressmassa med brett smaeltningsomraode, foerfarande foer framstaellning daerav och dess anvaendning
JO1610B1 (en) Tetrahydimidimidose compounds (1,4) benzodiazepine-2 thyonath anti-viral and anti-viral
DK0638068T3 (da) Fremgangsmåde til fremstilling af (S)-3-amino-1-substitueret-pyrrolidiner
EP0608212A4 (en) PROCESS FOR TREATING VIRAL INFECTIONS.
ES2157899T3 (es) Derivados de sampangina utiles como agentes antifungicos y antimicobacterianos.
TW327171B (en) 2-heteroaryl-5 for prevention or treatment of HIV infection
MX9403275A (es) Metilendioxi[3,'4':6,7]indolizino-[1,2-b]quinolinonas substituidas.
FR2713641B1 (fr) Dérivés de l'épi-épibatidine.
AU7416491A (en) Novel alpha-mannosidase and fucosidase inhibitors
PT96789A (pt) Processo de preparacao de um medicamento a base de lisados bacterianos
ITMI910319A0 (it) Processo di dealogenazione di 1,3-diossolani